Starting in Obesity & Weight Management
Omnia has built a first-of-its-kind outcomes initiative called The BEACON Study. This national, longitudinal research is designed to understand how obesity treatments like GLP-1s perform in real life, over time, and across diverse patient populations.
​
As demand for evidence-based, comprehensive care grows, so does the need for better tools, real-world data, and patient-centered approaches that last beyond the prescription.​​
​
A Focus on GLP-1 Medications
GLP-1s are transforming the treatment of obesity—but these therapies require more than just a prescription.
Omnia’s model is designed to support the unique clinical and behavioral needs associated with GLP-1s, helping both patients and providers navigate a more effective treatment journey.
Our approach includes:
By integrating clinical care, behavior change, and real-world data collection, Omnia ensures that GLP-1s deliver their full potential—driving not just weight loss, but sustainable, long-term health outcomes.
"Obesity care is complex, but with the right education, patient resources and data, primary care physicians can lead the charge. Omnia is making that possible."
– Dr. Carolynn Francavilla, Board-certified obesity specialist and member of the Obesity Medicine Association Board of Trustees.